Acurx Pharmaceuticals, Inc. (ACXP): 6 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jan 8, 2025 | Dean Jack H Director | 9,852 | $1.02 | $10.0K | no history |
| Jan 8, 2025 | Deluccia Robert J Director, TenPercentOwner | 49,261 | $1.02 | $50.2K | no history |
| Jan 8, 2025 | Donohue James J. Director | 9,852 | $1.02 | $10.0K | no history |
| Jan 8, 2025 | Luci David P Director, Officer, TenPercentOwner | 49,261 | $1.02 | $50.2K | no history |
| Jan 8, 2025 | Sailer Carl Director | 24,631 | $1.02 | $25.1K | no history |
| Jan 8, 2025 | Scodari Joseph C Director | 24,631 | $1.02 | $25.1K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.